Prophylactic Intranasal Mupirocin Before Total Knee Replacement
Yes, patients undergoing total knee replacement should receive prophylactic intranasal mupirocin (2% twice daily for 5 days) with or without chlorhexidine body washes, completed as close as possible to surgery (1-2 weeks before the procedure). This recommendation is based on strong evidence specifically for orthopedic surgery and has demonstrated significant reductions in surgical site infections.
Guideline-Based Recommendation
The 2024 European Society of Clinical Microbiology and Infectious Diseases guidelines provide a strong recommendation with moderate certainty of evidence for decolonization with mupirocin (with or without chlorhexidine) for both MSSA and MRSA carriers before cardiac and orthopedic surgery 1. This represents the most current and authoritative guidance available.
Key Implementation Details:
- Regimen: Mupirocin nasal ointment 2% applied twice daily for 5 days
- Timing: Complete the course 1-2 weeks before surgery
- Combination therapy: May be combined with chlorhexidine gluconate soap (40 mg/mL) for enhanced effect
- Completion: If the 5-day course cannot be completed preoperatively, finish it post-surgery 1
Supporting Evidence from Clinical Practice
Multiple studies demonstrate the effectiveness of this approach specifically in total knee arthroplasty:
A 2015 study showed a dramatic reduction in surgical site infections from 2.24% to 0.49% (p<0.001) using a protocol that included preoperative mupirocin nasal ointment and chlorhexidine wipes, even in a high-risk population with elevated BMI and ASA class 2
A 2003 study in orthopedic surgery involving metal prostheses demonstrated a reduction in MRSA surgical site infections from 23 per 1,000 operations to 3.3 per 1,000 (p<0.001) with perioperative mupirocin prophylaxis 3
Cost-effectiveness analysis confirms that empirical treatment with mupirocin before total joint arthroplasty is both cost-effective and clinically beneficial, remaining the best strategy even when mupirocin costs exceed $100 4
Important Considerations
Universal vs. Targeted Approach:
The evidence supports universal prophylaxis (treat-all strategy) rather than screen-and-treat approaches. This is more practical, cost-effective, and avoids delays in surgery 1, 4. A 2024 study found only 1.7% nasal MRSA colonization rates, and screening followed by selective treatment showed no statistical difference in infection rates compared to non-carriers 5.
FDA-Approved Formulation:
Critical caveat: Standard mupirocin ointment (for skin use) is NOT formulated for intranasal use 6. A separate FDA-approved formulation—mupirocin nasal ointment—must be used for intranasal application 1. The standard topical ointment contains polyethylene glycol and is contraindicated for mucosal surfaces 6.
Resistance Monitoring:
While mupirocin resistance remains low (2.3-10% in various studies), institutions should monitor local resistance patterns 3. The benefits of prophylaxis significantly outweigh resistance concerns in the orthopedic surgery setting 1.
Timing Optimization:
- Decolonization should be completed as close to surgery as possible (ideally 1-2 weeks before)
- For elective surgery, consider postponing the procedure if decolonization cannot be completed, provided this poses no additional patient risk 1
Clinical Algorithm
For all patients scheduled for total knee replacement:
- Prescribe mupirocin nasal ointment 2% (not standard topical ointment)
- Instruct twice-daily application for 5 consecutive days
- Schedule completion 1-2 weeks before surgery
- Consider adding chlorhexidine body washes for enhanced protection
- If course incomplete preoperatively → complete post-surgery
- Proceed with standard perioperative antibiotic prophylaxis (typically cefazolin ± vancomycin) separately 2
This approach provides maximal protection against Staphylococcus aureus surgical site infections, which represent a devastating complication in total knee arthroplasty with significant morbidity and mortality implications.